BWFA
ARNA

Baltimore-Washington Financial Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-100
Closed -$6K – 339
2014
Q2 		$6K Buy
+100
New +$6.3K ﹤0.01% 254

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baltimore-Washington Financial Advisors's ARNA Position: Q3 2014 in Review

Baltimore-Washington Financial Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2014, closing a stake of 100 shares — an estimated $6K sold.

Baltimore-Washington Financial Advisors first reported a position in ARNA in Q2 2014 and held it in 1 quarter. The position peaked at $6K in Q2 2014. 121 funds tracked by Wall St. Rank hold ARNA as of Q3 2014.

  • Baltimore-Washington Financial Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 100 Arena Pharmaceuticals Inc shares in Q3 2014, an estimated $6K.
  • Baltimore-Washington Financial Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2014 and held it in 1 quarter.
  • Baltimore-Washington Financial Advisors's Arena Pharmaceuticals Inc position peaked at $6K in Q2 2014.
  • 121 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2014.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.